Cdk2-dependent Phosphorylation of the NF-Y Transcription Factor and Its Involvement in the p53-p21 Signaling Pathway*

Recent studies have suggested that the NF-Y transcription factor is involved in transcription repression of the cell cycle regulatory genes in a response to p53 induction or DNA damage. Here we demonstrate the cdk2-dependent phosphorylation of NF-Y and its involvement in transcription repression by the p53-p21 signaling pathway. Cdk2 phosphorylates two serine residues near the DNA-binding domain of the YA subunit of NF-Y. Cyclin A-cdk2 appears to associate with NF-Y both in vitro and in vivo. Furthermore, YA protein is phosphorylated in parallel with a cell cycle-dependent activation of cdk2 kinase and cyclin A expression. YA phosphorylation is unnecessary for heterotrimer formation with the YB-YC dimer. However, NF-Y containing a phosphorylation-deficient mutant form of YA, YA-aa, has its DNA binding activity impaired. Consistently, YA-aa inhibits transcription activation of a NF-Y target promoter, cdc2, by cdk2. These results facilitate the elucidation of the regulatory mechanisms of cell cycle progression involving the p21-cdk2-NF-Y signaling pathway.

[1]  C. Dieffenbach,et al.  PCR primer: a laboratory manual. , 2003 .

[2]  A. Levine,et al.  Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression , 1995, Molecular and cellular biology.

[3]  Patrick Fojas de Borja,et al.  Cyclin A–CDK phosphorylates Sp1 and enhances Sp1‐mediated transcription , 2001, The EMBO journal.

[4]  C. Benoist,et al.  Dominant negative analogs of NF-YA. , 1994, The Journal of biological chemistry.

[5]  V. Georgiev.  Virology , 1955, Nature.

[6]  E. Coccia,et al.  Transcriptional regulation of the ferritin heavy-chain gene: the activity of the CCAAT binding factor NF-Y is modulated in heme-treated Friend leukemia cells and during monocyte-to-macrophage differentiation , 1997, Molecular and cellular biology.

[7]  J. Sedivy,et al.  Regulation of cyclin-Cdk activity in mammalian cells , 2002, Cellular and Molecular Life Sciences CMLS.

[8]  B. Crombrugghe,et al.  Role of the CCAAT-binding protein CBF/NF-Y in transcription. , 1998, Trends in biochemical sciences.

[9]  M. Tiainen,et al.  Down-regulation of cyclin B1 gene transcription in terminally differentiated skeletal muscle cells is associated with loss of functional CCAAT-binding NF-Y complex , 1999, Oncogene.

[10]  S. van den Heuvel,et al.  Distinct roles for cyclin-dependent kinases in cell cycle control. , 1993, Science.

[11]  C. Turck,et al.  Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit , 1993, Nature.

[12]  K. Chen,et al.  A specific CCAAT-binding protein, CBP/tk, may be involved in the regulation of thymidine kinase gene expression in human IMR-90 diploid fibroblasts during senescence. , 1993, The Journal of biological chemistry.

[13]  R. Mantovani,et al.  NF-Y Mediates the Transcriptional Inhibition of thecyclin B1, cyclin B2, and cdc25CPromoters upon Induced G2 Arrest* , 2001, The Journal of Biological Chemistry.

[14]  D. Landsman,et al.  A variety of DNA-binding and multimeric proteins contain the histone fold motif. , 1995, Nucleic acids research.

[15]  T. Shenk,et al.  Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  David Beach,et al.  p21 is a universal inhibitor of cyclin kinases , 1993, Nature.

[17]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[18]  M. Saville,et al.  The cell-cycle regulated transcription factor B-Myb is phosphorylated by Cyclin A/Cdk2 at sites that enhance its transactivation properties , 1998, Oncogene.

[19]  R. Mantovani,et al.  A survey of 178 NF-Y binding CCAAT boxes. , 1998, Nucleic acids research.

[20]  S. Maity,et al.  Three classes of mutations in the A subunit of the CCAAT-binding factor CBF delineate functional domains involved in the three-step assembly of the CBF-DNA complex , 1996, Molecular and cellular biology.

[21]  L Meijer,et al.  Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. , 1997, European journal of biochemistry.

[22]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[23]  C. Benoist,et al.  A multiplicity of CCAAT box-binding proteins , 1987, Cell.

[24]  C. Benoist,et al.  Intron-exon organization of the NF-Y genes. Tissue-specific splicing modifies an activation domain. , 1992, The Journal of biological chemistry.

[25]  G. Pfeifer,et al.  In vivo structure of the human cdc2 promoter: release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression , 1995, Molecular and cellular biology.

[26]  F. C. Lucibello,et al.  Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. , 1995, The EMBO journal.

[27]  S. Kim,et al.  Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest. , 2000, Cancer research.

[28]  E. White,et al.  Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein , 1995, Molecular and cellular biology.

[29]  P. Sperryn,et al.  Blood. , 1989, British journal of sports medicine.

[30]  D O Morgan,et al.  Cyclin-dependent kinases: engines, clocks, and microprocessors. , 1997, Annual review of cell and developmental biology.

[31]  K Nasmyth,et al.  Viewpoint: Putting the Cell Cycle in Order , 1996, Science.

[32]  A. van der Eb,et al.  Transformation of rat cells by DNA of human adenovirus 5. , 1973, Virology.

[33]  S H Kim,et al.  Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. , 1997, European journal of biochemistry.

[34]  H. Chae,et al.  p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor , 2001, Oncogene.

[35]  H. Choy,et al.  p53 Negatively Regulates cdc2 Transcription via the CCAAT-binding NF-Y Transcription Factor* , 1999, The Journal of Biological Chemistry.

[36]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]／Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[37]  D. Haber,et al.  The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. , 1995, Genes & development.

[38]  David O. Morgan,et al.  Principles of CDK regulation , 1995, Nature.

[39]  S. Namkoong,et al.  Growth Suppression of Ovarian Cancer Cells by Interferon-gama. , 2001, Cancer research and treatment : official journal of Korean Cancer Association.

[40]  G. Zambetti,et al.  Wild-type p53 binds to the TATA-binding protein and represses transcription. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Giovanna Marziali,et al.  The activity of the CCAAT-box binding factor NF-Y is modulated through the regulated expression of its a subunit during monocyte to macrophage differentiation : Regulation of tissue-specific genes through a ubiquitous transcription factor , 1999 .

[42]  M. Garabedian,et al.  Potentiation of Human Estrogen Receptor α Transcriptional Activation through Phosphorylation of Serines 104 and 106 by the Cyclin A-CDK2 Complex* , 1999, The Journal of Biological Chemistry.

[43]  C. Ra.  Biochemical Characterization of the NF-Y Transcription Factor Complex during B Lymphocyte Development , 1998 .